MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Benign Progressive Supranuclear Palsy: mild pathology associated with parkinsonism

B. Couto, I. Martinez-Balbuena, S. Lee, N. Visanji, A. Lang, G. Kovacs (Toronto, Canada)

Meeting: MDS Virtual Congress 2021

Abstract Number: 580

Keywords: Parkinsonism, Progressive supranuclear palsy(PSP), Tauopathies

Category: Parkinsonism, Atypical: PSP, CBD

Objective: Objective: To describe the clinical presentation and neuropathology of cases where the degree of tau pathology is mild, and the neuronal loss is anatomically restricted, suggestive of a benign form of Progressive Supranuclear Palsy (PSP).

Background: Background: After Richardson’s syndrome (PSP-RS), asymmetric parkinsonism with tremor is the second most common clinical presentation of PSP, or PSP with predominant-parkinsonism phenotype (PSP-P). PSP-P shows a longer disease duration and tau pathology has less cortical involvement than in PSP-RS.

Method: Methods: From our collection of pathologically confirmed PSP patients we identified patients with the minimal degree of pathology. A retrospective chart review and detailed neuropathology were conducted.

Results: Results: We identified two cases (age of death 73-year-old and 82-year-old) with a mild degree of tau pathology restricted to the substantia nigra, globus pallidus, and subthalamic nucleus associated with moderate nerve cell loss suggestive of an early stage-1 transition to stage-2 of the recently described 6-stages of PSP pathology [1]. Tau pathology was milder than in previously reported PSP-P cases. There was a lack of significant co-pathology including Lewy bodies. Unexpectedly, the disease duration was 9 and 12 years and the clinical presentation observed was asymmetric parkinsonism with one patient exhibiting an exquisite levodopa-response and levodopa-induced dyskinesia. Of note, none of the two patients received an in-life diagnosis of PSP.

Conclusion: Conclusions: In this report of two patients, a mild degree of restricted tau pathology associated with a long disease duration and a parkinsonism-predominant phenotype. Our observations suggest that in contrast to the more common PSP variants, especially PSP-RS, there is a less widespread form of pathological tau accumulation compatible with a benign PSP. This could be related to a less efficient seeding capacity or cell-to-cell propagation throughout the brain.

References: 1. Kovacs, G.G., Lukic, M.J., Irwin, D.J. et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140, 99–119 (2020)

To cite this abstract in AMA style:

B. Couto, I. Martinez-Balbuena, S. Lee, N. Visanji, A. Lang, G. Kovacs. Benign Progressive Supranuclear Palsy: mild pathology associated with parkinsonism [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/benign-progressive-supranuclear-palsy-mild-pathology-associated-with-parkinsonism/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/benign-progressive-supranuclear-palsy-mild-pathology-associated-with-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley